Table of Contents Author Guidelines Submit a Manuscript
Research Article

CRISPR/Cas9 genome editing of Epidermal Growth Factor Receptor sufficiently abolished oncogenicity in Anaplastic Thyroid cancer.

Received 20 October 2017; Revised 14 December 2017; Accepted 26 December 2017

Academic Editor: Robert Pichler